GLUE — Monte Rosa Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Monte Rosa Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	41.7	346	263	232	372
Net Total Receivables	—	—	7.66	0.505	0.173
Prepaid Expenses
Total Other Current Assets
Total Current Assets	43.6	349	276	236	377
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.62	12.3	61.9	62.6	56.3
Other Long Term Assets
Total Assets	49.4	366	342	304	439
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	29.3	16.6	25.6	46.6	157
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	30.3	18.8	71	125	216
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	19	348	271	179	223
Total Liabilities & Shareholders' Equity	49.4	366	342	304	439
Total Common Shares Outstanding